Sarcoma and Gist 2012 Sponsors

Novartis Farma S.p.A.

Via L.go Umberto Boccioni 1
 21010 Origgio (VA)
 Italy

Novartis is a leading Company committed to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. Our global Pharmaceuticals portfolio includes more than 60 key marketed products, many of which are innovative leaders in their therapeutic areas. Novartis Oncology pipeline received several awards. Glivec (imatinib mesylaie) is the standard of care for CML and GIST, being the drug that started the targeted therapy era.

Pfizer Pio

Medical Oncology Europe
 23-25 avenue Lannelongue
 75014 Paris
 France

Pfizer logo

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. Consistent with our responsibility as the world's leading biopharmaceutical company, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
 Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Pfizer Oncology is committed to continually investigating multiple pathways to treating cancer. We are committed to partnerships with professional and patient organizations that enhance patients' lives.
 Working together, we will advance the science to deliver the right drug, at the right time for each patient.

PharmaMar, S.A.

Avda. Los Reyes, 1
 P.I. La Mina Norte - Colmenar Viejo
 28770 Colmenar Viejo (Madrid)
 Spain

PharmaMar is a Spanish company, member of the Zeltia Group, and a leader in the development of antitumor drugs of marine origin.
 The oceans cover 70% of the Earth's surface, and correspond to 90% of the biosphere. For millions of years, innumerable forms of marine life have evolved to produce an immense variety of chemical entities of exclusive sophistication. Among these, there are molecules with potent biological activities, developed as a form of biochemical warfare to survive in an extremely competitive environment. PharmaMar has identified the antitumour potential of these molecules, and is actively developing them as innovative treatments for cancer.

Groupe Sarcome Français - Groupe d'Etude des Tumeurs Osseuses (GSF-GETO)

GSF-GETO-Logo

Centre Léon Bérard
 28 rue Laënnec
69373 Lyon Cedex 08
France
Website: www.gsf-geto.org

Réseaux de référence Sarcome RRePS / NetSarc

NetSarc-Logo

Website: www.netsarc.org - www.rreps.org

 

Takeda Pharmaceuticals Europe Ltd

61 Aldwych,
 London WC2B4AE
 United Kingdom

Takeda is a global research-based pharmaceutical company. Our mission is better health for patients worldwide through leading innovation in medicine. With oncology a key area of focus, our innovation will result in the discovery, development and delivery of high-quality, differentiated products focused on patient needs.

Infinity Pharmaceuticals, Inc.

780 Memorial Drive
 02139, Cambridge, MA
 United States of America

Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programmes in the inhibition of the Hedgehog pathway, the Hsp90 chaperone system and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development.